| CASE REPORT |
|
| Year : 2020 | Volume
: 17
| Issue : 3 | Page : 152-154 |
|
|
Multiple myeloma masquerading as T3 toxicosis
P Veechika, S Chitra
Department of Endocrinology, Ramaiah Medical College, Bengaluru, Karnataka, India
Correspondence Address:
Dr. S Chitra
Department of Endocrinology, Ramaiah Medical College, Bengaluru, Karnataka
India
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/trp.trp_46_20
|
|
|
We report a case of a 52-year-old man who was referred by his primary care physician to rule out thyroid illness. His thyroid function tests (TFTs) revealed isolated elevation of total T3 (TT3) with normal total T4 (TT4), free T3 (FT3), free T4 (FT4), and unsuppressed thyroid-stimulating hormone raising the suspicion of antibody interference or abnormal thyroid hormone-binding proteins. To identify antibody interference, we repeated the immunoassay using varied platforms and assay methods. The total T3 levels which were high in one-step immunoassay normalized in two-step immunoassay. On further evaluation, the patient was diagnosed with multiple myeloma and the antibody interference was secondary to IgG monoclonal antibody binding specifically to analog T3 leading to spurious results. Ours is the first report from India and the fourth case in literature to report a multiple myeloma antibody interfering with TFTs.
|
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
Next article
